Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 229,055,885 papers from all fields of science
Search
Sign In
Create Free Account
Peroxisome Biogenesis Disorder, Complementation Group G
Known as:
CGG
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Peroxisomal Disorders
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Selective executive markers of at-risk profiles associated with the fragile X premutation
K. Cornish
,
D. Hocking
,
S. Moss
,
C. Kogan
Neurology
2011
Corpus ID: 18640051
Objective: This study determined whether CGG repeat length moderates the relationship between age and performance on selective…
Expand
2010
2010
Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertile women and egg donors.
N. Gleicher
,
A. Weghofer
,
D. Barad
Reproductive Biomedicine Online
2010
Corpus ID: 28491510
Highly Cited
1999
Highly Cited
1999
Expansion and Deletion of Triplet Repeat Sequences inEscherichia coli Occur on the Leading Strand of DNA Replication*
R. Iyer
,
R. Wells
Journal of Biological Chemistry
1999
Corpus ID: 1997221
Expansions and deletions of triplet repeat sequences that cause human hereditary neurological diseases were previously suggested…
Expand
Highly Cited
1996
Highly Cited
1996
FMR1 in global populations.
Catherine B. Kunst
,
C. Zerylnick
,
+7 authors
S. Warren
American Journal of Human Genetics
1996
Corpus ID: 22491313
Fragile X syndrome, a frequent form of inherited mental retardation, results from the unstable expansion of a cryptic CGG repeat…
Expand
1996
1996
CTG Triplet Repeats from Human Hereditary Diseases Are Dominant Genetic Expansion Products in Escherichia coli(*)
K. Ohshima
,
S. Kang
,
R. Wells
Journal of Biological Chemistry
1996
Corpus ID: 10351760
The relative ability of the 10 triplet repeat sequences to be expanded in Escherichia coli was determined. Surprisingly, CTG…
Expand
Highly Cited
1995
Highly Cited
1995
Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor.
E. Graaff
,
R. Willemsen
,
+4 authors
B. Oostra
American Journal of Human Genetics
1995
Corpus ID: 2660488
The molecular mechanism of the fragile X syndrome is based on the expansion of an CGG repeat in the 5' UTR of the FMR1 gene in…
Expand
Highly Cited
1994
Highly Cited
1994
Emotional and neurocognitive deficits in fragile X.
W. Sobesky
,
W. Sobesky
,
+4 authors
R. Hagerman
American journal of medical genetics
1994
Corpus ID: 25177678
We have studied the neurocognitive deficit in premutation and full mutation women as compared to control women and to explore the…
Expand
Highly Cited
1994
Highly Cited
1994
Loss of mutation at the FMR1 locus through multiple exchanges between maternal X chromosomes.
A. V. D. van den Ouweland
,
W. Deelen
,
+5 authors
D. Halley
Human Molecular Genetics
1994
Corpus ID: 2491569
The mutation observed in the fragile X syndrome, an X-linked inherited disorder causing mental retardation, is almost exclusively…
Expand
Highly Cited
1993
Highly Cited
1993
Mental Status and Fragile X Expression in Relation to FMR-1 Gene Mutation
B. Vries
,
A. Wiegers
,
+7 authors
B. Oostra
European Journal of Human Genetics
1993
Corpus ID: 23014518
The fragile X mental retardation syndrome is caused by unstable expansion of a CGG repeat in the FMR-1 gene. Clinical expression…
Expand
Highly Cited
1993
Highly Cited
1993
A study of the physical, behavioral, and medical phenotype, including anthropometric measures, of females with fragile X syndrome.
Claire E. Hull
,
Randi J Hagerman
A M A Journal of Diseases of Children
1993
Corpus ID: 39245796
The physical features of fragile X, including a long face, prominent ears, and hyperextensible joints, are present in affected…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE